{
    "title": "Lilly migraine treatment meets main goal in late-stage studies",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4499528/Lilly-migraine-treatment-meets-main-goal-late-stage-studies.html",
    "date": "2017-05-12",
    "keywords": [
        "migraine",
        "drug",
        "galcanezumab",
        "headache",
        "latestage",
        "study",
        "reduction",
        "pain",
        "amgen",
        "inc",
        "berenberg",
        "sutcliffe",
        "novartis",
        "treatment",
        "mg",
        "baseline",
        "average",
        "debilitating",
        "disease",
        "healthcare",
        "productivity",
        "research",
        "foundation",
        "lillys",
        "population",
        "form",
        "condition",
        "alder",
        "protein",
        "cgrp",
        "analyst",
        "laura",
        "data",
        "set",
        "news",
        "track",
        "leader",
        "space",
        "colucid",
        "year",
        "heft",
        "portfolio",
        "slice",
        "market",
        "trial",
        "mean",
        "gap",
        "client",
        "note",
        "goal",
        "marketing",
        "application",
        "food",
        "administration",
        "half",
        "placebo",
        "arm",
        "month",
        "company",
        "cluster",
        "clarivate",
        "reporting",
        "banerjee",
        "bengaluru",
        "editing",
        "shounak",
        "dasgupta"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}